Skip to main content
Equibles
TNBI logo

TNBI · Tanke Biosciences Corp · Metrics

Track TNBI — free

Use TNBI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TNBI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 -0.02 (-60.32%) At close · Sep 17
Rebalance outlook locked
Market Cap
$266,481
Shares
13.32M

TNBI metrics

52 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$266,481

Price action

20 metrics
Price change (1W)
—
Price change (30D)
+68.0%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
-16.0%
Price change (1Y)
-37.0%
Trailing year
Price change (5Y)
-97.5%
52-week high
$0.06
52-week low
$0.02
Change from 52-week high
-58.0%
Change from 52-week low
+68.0%
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
45.2
Price vs SMA 50
-38.0%
Price vs SMA 200
-6.2%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Financial Services
Industry
Asset Management
Shares outstanding
13.32M

Valuation

12 metrics
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 793.7%
PEG ratio
—
EV / revenue
-0.1×
EV / EBITDA
-4.0×
EV / EBIT
—
P / sales
0.0×
reciprocal yield 8,616.1%
P / book
0.0
reciprocal yield 5,837.6%
FCF yield
-2,299.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-615.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
32.3%
Operating margin
-0.2%
Trailing 12 months
Net margin
-7.1%
Gross profit (TTM)
$7.41M
Operating profit (TTM)
−$57,268
Net income (TTM)
−$1.64M
Trailing 12 months
Diluted EPS (TTM)
$0.20
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.18

Growth

11 metrics
Revenue growth YoY
-39.0%
Year over year
Net income growth YoY
-131.2%
Revenue (TTM)
$22.96M
Trailing 12 months
EPS growth YoY
-170.6%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-10.5%
Return on assets
-5.7%
Debt / equity
0.1
Current ratio
1.6
EBITDA (TTM)
$723,273
Free cash flow (TTM)
−$6.13M
Quick ratio
1.5
Interest coverage
-0.1
Net debt / EBITDA
-4.4
Return on invested capital
—
Trailing 12 months
Net cash
$3.18M
Latest balance sheet
Cash & equivalents
$5.05M
Total assets
$28.81M
Total debt
$1.87M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.64M
Capital expenditures (TTM)
$2.49M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$375,938
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1452011 Visit website